Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Azim Ansari

Showing results (41-50 of 92) with videos related to

Pageof 10
Sort By:
Sexually Transmitted Infections|June 24, 2024
Multiple risk factors for persistent HBV viraemia in an adult receiving nucleos/tide analogue therapySheila Lumley, Maeve Barlow, Khadija Said, et al.
Nature Communications|October 21, 2021
Viral genome wide association study identifies novel hepatitis C virus polymorphisms associated with sofosbuvir treatment failureDavid A Smith, Carlota Fernandez-Antunez, Andrea Magri, et al.
The Journal of Infectious Diseases|July 24, 2020
Simultaneous Viral Whole-Genome Sequencing and Differential Expression Profiling in Respiratory Syncytial Virus Infection of InfantsGu-Lung Lin, Tanya Golubchik, Simon Drysdale, et al.
Frontiers in Microbiology|November 9, 2020
Technical Validation of a Hepatitis C Virus Whole Genome Sequencing Assay for Detection of Genotype and Antiviral Resistance in the Clinical PathwayCarmen F Manso, David F Bibby, Kieren Lythgow, et al.
BMC Medicine|February 22, 2019
HBV vaccination and PMTCT as elimination tools in the presence of HIV: insights from a clinical cohort and dynamic modelAnna L McNaughton, José Lourenço, Louise Hattingh, et al.
Cell Reports|October 12, 2025
Interplay of host and viral genetic variations in modulating antibody responses to genotype 3a hepatitis C virus: Implications for vaccine designZhiqing Wang, Isla Humphreys, Jocelyn Quistrebert, et al.
Scientific Reports|May 10, 2019
Illumina and Nanopore methods for whole genome sequencing of hepatitis B virus (HBV)Anna L McNaughton, Hannah E Roberts, David Bonsall, et al.
Gastroenterology|May 13, 2019
Amino Acid Substitutions in Genotype 3a Hepatitis C Virus Polymerase Protein Affect Responses to SofosbuvirPeter A C Wing, Meleri Jones, Michelle Cheung, et al.
BMC Public Health|December 19, 2023
HepFREEPak: protocol for a multi-centre, prospective observational study examining efficacy and impact of current therapies for the treatment of hepatitis C in Pakistan and reporting resistance to antiviral drugs: study protocolAmbreen Arif, Aliya Hasnain, Auj Chaudhry, et al.
JHEP Reports : Innovation in Hepatology|November 22, 2021
Performance of models to predict hepatocellular carcinoma risk among UK patients with cirrhosis and cured HCV infectionHamish Innes, Peter Jepsen, Scott McDonald, et al.
Pageof 10

Showing results (41-50 of 92) with videos related to

Sort By:
Pageof 10
Sexually Transmitted Infections|June 24, 2024
Multiple risk factors for persistent HBV viraemia in an adult receiving nucleos/tide analogue therapySheila Lumley, Maeve Barlow, Khadija Said, et al.
Nature Communications|October 21, 2021
Viral genome wide association study identifies novel hepatitis C virus polymorphisms associated with sofosbuvir treatment failureDavid A Smith, Carlota Fernandez-Antunez, Andrea Magri, et al.
The Journal of Infectious Diseases|July 24, 2020
Simultaneous Viral Whole-Genome Sequencing and Differential Expression Profiling in Respiratory Syncytial Virus Infection of InfantsGu-Lung Lin, Tanya Golubchik, Simon Drysdale, et al.
Frontiers in Microbiology|November 9, 2020
Technical Validation of a Hepatitis C Virus Whole Genome Sequencing Assay for Detection of Genotype and Antiviral Resistance in the Clinical PathwayCarmen F Manso, David F Bibby, Kieren Lythgow, et al.
BMC Medicine|February 22, 2019
HBV vaccination and PMTCT as elimination tools in the presence of HIV: insights from a clinical cohort and dynamic modelAnna L McNaughton, José Lourenço, Louise Hattingh, et al.
Cell Reports|October 12, 2025
Interplay of host and viral genetic variations in modulating antibody responses to genotype 3a hepatitis C virus: Implications for vaccine designZhiqing Wang, Isla Humphreys, Jocelyn Quistrebert, et al.
Scientific Reports|May 10, 2019
Illumina and Nanopore methods for whole genome sequencing of hepatitis B virus (HBV)Anna L McNaughton, Hannah E Roberts, David Bonsall, et al.
Gastroenterology|May 13, 2019
Amino Acid Substitutions in Genotype 3a Hepatitis C Virus Polymerase Protein Affect Responses to SofosbuvirPeter A C Wing, Meleri Jones, Michelle Cheung, et al.
BMC Public Health|December 19, 2023
HepFREEPak: protocol for a multi-centre, prospective observational study examining efficacy and impact of current therapies for the treatment of hepatitis C in Pakistan and reporting resistance to antiviral drugs: study protocolAmbreen Arif, Aliya Hasnain, Auj Chaudhry, et al.
JHEP Reports : Innovation in Hepatology|November 22, 2021
Performance of models to predict hepatocellular carcinoma risk among UK patients with cirrhosis and cured HCV infectionHamish Innes, Peter Jepsen, Scott McDonald, et al.
Pageof 10